Cargando…

Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS

Recent studies concerning products that originate from natural plants have sought to clarify active ingredients, which both explains the mechanisms of the function and aids in quality control during production. As a traditional functional plant, Curcumae Rhizoma (CR) has been proven to be effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Zhenwei, Zhang, Ying, Sun, Yue, Wang, Lvhong, Huang, Yuting, Cao, Hui, Wang, Shumei, Meng, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703108/
https://www.ncbi.nlm.nih.gov/pubmed/34955839
http://dx.doi.org/10.3389/fphar.2021.769021
_version_ 1784621388598870016
author Lan, Zhenwei
Zhang, Ying
Sun, Yue
Wang, Lvhong
Huang, Yuting
Cao, Hui
Wang, Shumei
Meng, Jiang
author_facet Lan, Zhenwei
Zhang, Ying
Sun, Yue
Wang, Lvhong
Huang, Yuting
Cao, Hui
Wang, Shumei
Meng, Jiang
author_sort Lan, Zhenwei
collection PubMed
description Recent studies concerning products that originate from natural plants have sought to clarify active ingredients, which both explains the mechanisms of the function and aids in quality control during production. As a traditional functional plant, Curcumae Rhizoma (CR) has been proven to be effective in promoting blood circulation and removing blood stasis. However, the components that play a role in its huge compound library are still unclear. The present study aimed to develop a high-throughput screening method to identify thrombin inhibitors in CR and validate them by in vitro and in vivo experiments. The effect of CR on thrombin in HUVECs cells was determined by ELISA, then an affinity-ultrafiltration-UPLC-Q-Exactive Orbitrap/MS approach was applied. Agatroban and adenosine were used as positive and negative drugs respectively to verify the reliability of the established method. The in vitro activity of the compounds was determined by specific substrate S-2238. The in vivo effect of the active ingredients was determined using zebrafish. Molecular docking was used to understand the internal interactions between compounds and enzymes. ELISA results showed that CR had an inhibitory effect on thrombin. The screening method established in this paper is reliable, by which a total of 15 active compounds were successfully identified. This study is the first to report that C7, 8, and 11 have in vitro thrombin-inhibitory activity and significantly inhibit thrombosis in zebrafish models at a safe dose. Molecular docking studies were employed to analyze the possible active binding sites, with the results suggesting that compound 16 is likely a better thrombin inhibitor compared with the other compounds. Based on the affinity-ultrafiltration-UPLC-Q-Exactive Orbitrap/MS approach, a precisely targeted therapy method using bio-active compounds from CR might be successfully established, which also provides a valuable reference for targeted therapy, mechanism exploration, and the quality control of traditional herbal medicine.
format Online
Article
Text
id pubmed-8703108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87031082021-12-25 Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS Lan, Zhenwei Zhang, Ying Sun, Yue Wang, Lvhong Huang, Yuting Cao, Hui Wang, Shumei Meng, Jiang Front Pharmacol Pharmacology Recent studies concerning products that originate from natural plants have sought to clarify active ingredients, which both explains the mechanisms of the function and aids in quality control during production. As a traditional functional plant, Curcumae Rhizoma (CR) has been proven to be effective in promoting blood circulation and removing blood stasis. However, the components that play a role in its huge compound library are still unclear. The present study aimed to develop a high-throughput screening method to identify thrombin inhibitors in CR and validate them by in vitro and in vivo experiments. The effect of CR on thrombin in HUVECs cells was determined by ELISA, then an affinity-ultrafiltration-UPLC-Q-Exactive Orbitrap/MS approach was applied. Agatroban and adenosine were used as positive and negative drugs respectively to verify the reliability of the established method. The in vitro activity of the compounds was determined by specific substrate S-2238. The in vivo effect of the active ingredients was determined using zebrafish. Molecular docking was used to understand the internal interactions between compounds and enzymes. ELISA results showed that CR had an inhibitory effect on thrombin. The screening method established in this paper is reliable, by which a total of 15 active compounds were successfully identified. This study is the first to report that C7, 8, and 11 have in vitro thrombin-inhibitory activity and significantly inhibit thrombosis in zebrafish models at a safe dose. Molecular docking studies were employed to analyze the possible active binding sites, with the results suggesting that compound 16 is likely a better thrombin inhibitor compared with the other compounds. Based on the affinity-ultrafiltration-UPLC-Q-Exactive Orbitrap/MS approach, a precisely targeted therapy method using bio-active compounds from CR might be successfully established, which also provides a valuable reference for targeted therapy, mechanism exploration, and the quality control of traditional herbal medicine. Frontiers Media S.A. 2021-12-10 /pmc/articles/PMC8703108/ /pubmed/34955839 http://dx.doi.org/10.3389/fphar.2021.769021 Text en Copyright © 2021 Lan, Zhang, Sun, Wang, Huang, Cao, Wang and Meng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lan, Zhenwei
Zhang, Ying
Sun, Yue
Wang, Lvhong
Huang, Yuting
Cao, Hui
Wang, Shumei
Meng, Jiang
Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS
title Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS
title_full Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS
title_fullStr Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS
title_full_unstemmed Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS
title_short Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS
title_sort identifying of anti-thrombin active components from curcumae rhizoma by affinity-ultrafiltration coupled with uplc-q-exactive orbitrap/ms
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703108/
https://www.ncbi.nlm.nih.gov/pubmed/34955839
http://dx.doi.org/10.3389/fphar.2021.769021
work_keys_str_mv AT lanzhenwei identifyingofantithrombinactivecomponentsfromcurcumaerhizomabyaffinityultrafiltrationcoupledwithuplcqexactiveorbitrapms
AT zhangying identifyingofantithrombinactivecomponentsfromcurcumaerhizomabyaffinityultrafiltrationcoupledwithuplcqexactiveorbitrapms
AT sunyue identifyingofantithrombinactivecomponentsfromcurcumaerhizomabyaffinityultrafiltrationcoupledwithuplcqexactiveorbitrapms
AT wanglvhong identifyingofantithrombinactivecomponentsfromcurcumaerhizomabyaffinityultrafiltrationcoupledwithuplcqexactiveorbitrapms
AT huangyuting identifyingofantithrombinactivecomponentsfromcurcumaerhizomabyaffinityultrafiltrationcoupledwithuplcqexactiveorbitrapms
AT caohui identifyingofantithrombinactivecomponentsfromcurcumaerhizomabyaffinityultrafiltrationcoupledwithuplcqexactiveorbitrapms
AT wangshumei identifyingofantithrombinactivecomponentsfromcurcumaerhizomabyaffinityultrafiltrationcoupledwithuplcqexactiveorbitrapms
AT mengjiang identifyingofantithrombinactivecomponentsfromcurcumaerhizomabyaffinityultrafiltrationcoupledwithuplcqexactiveorbitrapms